DUBLIN, April 19, 2018 /PRNewswire/ --
The "Global Cancer Pain Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.
The research provides insights into Cancer Pain epidemiology, Cancer Pain diagnosed patients, and Cancer Pain treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Cancer Pain derived from epidemiological analysis, patients diagnosed with Cancer Pain, and patients treated with a drug therapy.
The research study helps executives estimate Cancer Pain market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The research provides estimates and forecasts of Cancer Pain prevalence, Cancer Pain diagnosis rate, and Cancer Pain treatment rate for the period 2017 - 2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.
Key Topics Covered:
1. Cancer Pain: Disease Definition
2. Global Cancer Pain Patient Flow
2A. Global Cancer Pain Prevalence
2B. Global Cancer Pain Diagnosed Patients
2C. Global Cancer Pain Treated Patients
3. Cancer Pain Patient Flow in the US
3A. Cancer Pain Prevalence in the US
3B. Cancer Pain Diagnosed Patients in the US
3C. Cancer Pain Treated Patients in the US
4. Cancer Pain Patient Flow in Europe
4A. Cancer Pain Prevalence in Europe
4B. Cancer Pain Diagnosed Patients in Europe
4C. Cancer Pain Treated Patients in Europe
5. Cancer Pain Patient Flow in Germany
5A. Cancer Pain Prevalence in Germany
5B. Cancer Pain Diagnosed Patients in Germany
5C. Cancer Pain Treated Patients in Germany
6. Cancer Pain Patient Flow in France
6A. Cancer Pain Prevalence in France
6B. Cancer Pain Diagnosed Patients in France
6C. Cancer Pain Treated Patients in France
7. Cancer Pain Patient Flow in Spain
7A. Cancer Pain Prevalence in Spain
7B. Cancer Pain Diagnosed Patients in Spain
7C. Cancer Pain Treated Patients in Spain
8. Cancer Pain Patient Flow in Italy
8A. Cancer Pain Prevalence in Italy
8B. Cancer Pain Diagnosed Patients in Italy
8C. Cancer Pain Treated Patients in Italy
9. Cancer Pain Patient Flow in UK
9A. Cancer Pain Prevalence in UK
9B. Cancer Pain Diagnosed Patients in UK
9C. Cancer Pain Treated Patients in UK
10. Cancer Pain Patient Flow in Japan
10A. Cancer Pain Prevalence in Japan
10B. Cancer Pain Diagnosed Patients in Japan
10C. Cancer Pain Treated Patients in Japan
For more information about this report visit
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets